Remiges BioPharma Fund, LP — Form D/A
Remiges BioPharma Fund, LP of CAMBRIDGE, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2017-03-09. The offering totals $80.0M, of which $80.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-03-09
- Form: D/A
- Accession: 0001609623-17-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $80.0M
- Amount sold: $80.0M
- Investors: 4
- Date of first sale: 2014-06-06
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-218532
Issuer
- Name: Remiges BioPharma Fund, LP
- CIK: 0001609623
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2014
- Address: ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, 02142
- Phone: (617) 401-2136
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Taro Inaba | Director | TOKYO, M0 |
| Walter Olesiak | Director | New York, NY |
| Walter Olesiak | Executive Officer | New York, NY |
| N/A REMIGES BIOPHARMA FUND GP, INC. | Executive Officer | CAMBRIDGE, MA |
Other filings by this issuer (2)
More